Scott Schlackman - Mar 10, 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves attorney-in-fact
Stock symbol
MED
Transactions as of
Mar 10, 2023
Transactions value $
-$178,200
Form type
4
Date filed
3/14/2023, 06:09 PM
Previous filing
Feb 9, 2023
Next filing
May 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Options Exercise $60.9K +2.2K +30.22% $27.68 9.48K Mar 10, 2023 Direct
transaction MED Common Stock Sale -$239K -2.2K -23.21% $108.68 7.28K Mar 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MED Stock Option (Right to Buy) Options Exercise $0 -2.2K -62.86% $0.00 1.3K Mar 10, 2023 Common Stock 2.2K $27.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.